Abo Pharmaceuticals is categorized under Wholesale Pharmaceutical Products in San Diego, CA and active since 1979.
Abo Pharmaceuticals was established in 1979, and today employs 1 to 4, earning $10.000.000 to $19.9999.999 per year. This is a Wholesale Pharmaceutical Products business, which does work in the B2B market, and is classified as a Wholesale Pharmaceutical Products, under code number by the NAICS.
If you are seeking more information, feel free to contact Joseph Schulmann at the company’s headquarters by writing to 7930 Arjons Dr # A, San Diego, California CA 92126 or by phoning (949) 699-2727. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Abo Pharmaceuticals |
Contact Person: | Joseph Schulmann |
Address: | 7930 Arjons Dr # A, San Diego, California 92126 |
Phone Number: | (949) 699-2727 |
Website Address: | abopharmaceuticals.com |
Annual Revenue (USD): | $10.000.000 to $19.9999.999 |
Founded: | 1979 |
Location Type: | Headquarters |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Wholesale Pharmaceutical Products |
Share This Business: |
Abo Pharmaceuticals was started in 1979 to provide professional Wholesale Pharmaceutical Products under the SIC code and NAICS code . Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $10.000.000 to $19.9999.999 per annum.
Feel free to contact Joseph Schulmann for inquiries that concern Abo Pharmaceuticals by calling the company number (949) 699-2727, as your correspondence is most welcome. Additionally, the physical location of the headquarters of Abo Pharmaceuticals can be found at the coordinates 32.89112,-117.15092 as well as the street address 7930 Arjons Dr # A in San Diego, California 92126.
For its online presence, you may visit Abo Pharmaceuticals’s website at abopharmaceuticals.com and engage with its social media outlets through on Twitter and on Facebook.